Source MS Trust: Sativex is a cost-effective treatment for people with MS spasticity according to new guidance published today by NICE(link is external). This reverses the decision made in draft guidance published earlier this year.
Source MS Trust: Lemtrada (alemtuzumab) should be restricted to people with highly active relapsing-remitting MS according to a review carried out by the European Medicines Agency's (EMA) drug safety committee.
Source BBC: Two cannabis-based medicines, used to treat epilepsy and multiple sclerosis, have been approved for use by the NHS in England.
Source MS Trust: This study set out to test the benefits of regular home-based standing combined with strengthening and balance exercises for people with progressive MS.
People with progressive MS with severe walking problems (122 people) were recruited through NHS clinics and therapy...
Source BBC: "I don't like to think of the future. It's such a big question mark. I just keep living in the present."Source BBC: "I don't like to think of the future. It's such a big question mark. I just keep living in the present."
Source MS Society: I find travelling stressful. Having to deal with invisible symptoms from MS has made it harder. I worry about being judged by other people if I need assistance when I may look fine.
Source MS Trust: Action potential simulation is a complementary therapy which some people use as a treatment for pain in MS. It’s available at some MS Therapy Centres in the UK. (Note we provide this at the Berkshire MS Therapy Centre for more info on our service click here...
Source MS Trust: The ECTRIMS (European Committee for Treatment and Research In Multiple Sclerosis) is the largest annual international conference devoted to basic and clinical research in multiple sclerosis. The 2019 meeting took place in Stockholm from 11 to 13 September.